Could a pill that calms brain inflammation slow Parkinson's?
NCT ID NCT07157735
Summary
This trial is testing whether a new drug called dapansutrile can slow the progression of Parkinson's disease by reducing inflammation in the brain and body. Researchers will enroll 36 people with early-stage Parkinson's to take either the drug or a placebo pill daily for six months, followed by an optional six-month period where everyone gets the drug. The main goals are to see if the drug is safe and if it lowers levels of inflammation in the blood, spinal fluid, and brain.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
John Van Geest Centre for Brain Repair
RECRUITINGCambridge, CB2 0PY, United Kingdom
Conditions
Explore the condition pages connected to this study.